Home Compare CELH vs ZEAL.CO
Stock Comparison · Structural lead, mixed market

Celsius Holdings vs Zealand Pharma A/S: Which Stock Looks Stronger in 2026?

Zealand Pharma A/S holds the cleaner structural position, with the lead spread across valuation and profitability. Celsius does not offset that deficit through any equally strong structural edge elsewhere. Both sides have seen trend damage — neither carries a clear market edge right now. With both trends damaged, the structural comparison carries most of the weight here.

The comparison is based on similar long-term financial trajectories, not sector labels.

Updated 2026-04-05

This is not just a one-metric split: both valuation and profitability materially support the lead. The overall score gap is 56 points in favour of Zealand Pharma A/S.

Trajectory Similarity
0.71
Similar
Peer-set rank: #3
within Celsius Holdings, Inc.'s functional peer set

This pair is matched through long-term financial trajectory similarity within the selected peer universe.

This level of similarity signals a strong structural match, even though some dimensions still separate the two companies.

The clearest structural overlap shows up in investment intensity and margin trend.

Similarity drivers
investment intensitymargin trend
What reduces the match
recent revenue growth
How to read the score
0.85–1.00 · Very similar0.70–0.84 · Similar0.55–0.69 · Moderately similarbelow 0.55 · Loose match
Peer-Relative Score
CELH
Celsius Holdings, Inc.
28
Peer-Score
Signal qualityMedium
vs
ZEAL.CO
Zealand Pharma A/S
84
Peer-Score
Signal qualityHigh

Scores reflect position relative to comparable companies with similar long-term financial trajectories.

The largest gaps do not all point in the same direction.

Dimension spread: CELH vs ZEAL.CO Profitability 25 100 Stability 30 36 Valuation 10 88 Growth 56 100 CELH ZEAL.CO
Gap Ranking
#1 Valuation +78
#2 Profitability +75
#3 Growth +44
#4 Stability +6
Price Setup

Left means cheaper relative valuation. Higher means stronger structure.

Price setup map for CELH and ZEAL.CO Stronger + cheaper Stronger + richer Weaker + cheaper Weaker + richer CELHZEAL.CO Relative valuation Structural strength

Zealand Pharma A/S looks stronger both structurally and on relative valuation.

Valuation position uses peer-relative PE percentile (idx_pct_pe) where available.

Relative Position vs Comparable Companies
Valuation
Zealand Pharma A/S ranks near the top of the group on valuation; Celsius Holdings, Inc. sits in the weaker half.
Profitability
The same broad pattern appears on profitability: Zealand Pharma A/S ranks near the top of the group, while Celsius Holdings, Inc. stays in the weaker half.
Valuation — Dominant Gap
CELH
10
ZEAL.CO
88
Gap+78in favour of ZEAL.CO

The multiple-based pricing edge comes from a trailing P/E that is 155 turns lower.

What keeps the gap from being one-sided

Celsius Holdings, Inc. still shows lower market-fundamental divergence, which keeps the wider picture mixed rather than completely one-sided.

What this means for the comparison

The lead is built on both valuation and profitability, making it broader than a single-dimension result.

Explore full peer positioning in AssetNext

Break down the CELH vs ZEAL.CO comparison across all dimensions with the full interactive tool.

Explore full breakdown →
Similar valuation-and-profitability comparisons

Explore how CELH and ZEAL.CO each compare against other companies in their peer groups.

Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.

How AssetNext Peer Scores Work

AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.

Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.

Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.